Prevent utilization of mixed agonist/antagonist (eg, pentazocine, nalbuphine, and butorphanol) or partial agonist (eg, buprenorphine) analgesics in people that are getting a full opioid agonist analgesic; mixed agonist/antagonist and partial agonist analgesics may well decrease analgesic result and/or precipitate withdrawal signs and symptoms; when